Rani Therapeutics Holdings RANI

NASDAQ RANI

$0.84 +0.02 (+2.51%)

At close: Sep 11, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) FCF Margin Growth (5y) (2025 - 2026)

Analysis

Rani Therapeutics Holdings (RANI) FCF Margin Growth (5y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Amgen	203.97 Bn	189.99 Bn	7.24 Bn
2	Gilead Sciences	178.74 Bn	175.56 Bn	6.22 Bn
3	Vertex Pharmaceuticals	130.73 Bn	122.88 Bn	2.84 Bn
4	Regeneron Pharmaceuticals	80.42 Bn	72.42 Bn	3.93 Bn
5	Argenx Se	60.40 Bn	55.21 Bn	1.37 Bn
6	Moderna	57.65 Bn	52.52 Bn	52.00 Mn
7	Alnylam Pharmaceuticals	33.37 Bn	30.07 Bn	992.69 Mn
8	Biogen	32.15 Bn	30.86 Bn	1.96 Bn
9	Roivant Sciences	29.58 Bn	29.58 Bn	1.16 Mn
10	Rani Therapeutics Holdings	157.97 Mn	157.97 Mn	-

Historic Data

Historic Data

Download Data

Date	Value
Jun 30, 2026	-23,622.00
Mar 31, 2026	16,710.00
Dec 31, 2025	333,250.00

Rani Therapeutics Holdings

NASDAQ: RANI

$0.84 ▲ +0.02 (+2.51%)

Sep 11, 2026 · 4:00 PM EDT